Alzheimer’s Disease with Psychosis
The Alzheimer’s Disease with Psychosis Study will enroll participants between the ages of 55-90 years old, inclusive, who have Alzheimer’s Disease and experience symptoms of psychosis at study centers throughout North America and Europe. This study involves taking an oral capsule, daily for the duration of the study. In addition, participants will receive support for their time and travel. No health insurance is required.